Boston Scientific Corporation (BSX) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Marlborough, MA, アメリカ. 現CEOは Michael F. Mahoney.
BSX を有する IPO日 1992-05-19, 53,000 名の正社員, に上場 NYSE, 時価総額 $94.85B.
Boston Scientific Corporation is a global medical device manufacturer that develops, manufactures, and markets innovative devices across interventional medical specialties. Operating through three primary segments—MedSurg, Rhythm and Neuro, and Cardiovascular—the company serves diverse therapeutic areas including gastrointestinal and pulmonary diagnostics, urology, cardiac rhythm management, neurostimulation, and interventional cardiology. Its comprehensive product portfolio encompasses implantable cardiac devices, ablation systems, coronary stents, peripheral vascular interventions, and oncology treatment solutions. Headquartered in Marlborough, Massachusetts, Boston Scientific has established itself as a leading provider of minimally invasive medical technologies that improve patient outcomes across multiple healthcare markets worldwide.